Ledger.Open graph →
SEC Form D · filed October 31, 2024

Garuda Therapeutics, Inc

Offering
—
Sold
$47.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Rahul Singhvi · Cambridge, MADirectorEric Aguiar · Cambridge, MADirectorGeoff Meyerson · Cambridge, MADirectorAdam Craig · Cambridge, MAExec · DirectorDavid Kirske · Cambridge, MAExecDavid M. Carver · Cambridge, MAExec · DirectorCarl Gordon · Cambridge, MADirectorSteve Liapis · Cambridge, MADirectorRaymond Kelleher · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗